Hepatitis C Articles (HCV)
Back
 
HCV at EACS: Mortality/SVR; 8 Weeks Harvoni COinfected & mono infected; HCC increasing; Abbvie 3D in Coinfected; ChemSex & HCV in London
EACS:
Sofosbuvir plus ledipasvir for 8 weeks in HCV-mono- and HIV-HCV-coinfected patients - Results from the German hepatitis C cohort (GECCO)
(10/27/15)
EACS:
Is Response to Anti-HCV Treatment Predictive of Mortality in HCV/HIV Co-infected Patients?..... "SVR -reduced incidence of liver-related death and improved overall survival"
(10/27/15)
EACS:
Trends in incidences and risk factors for hepatocellular carcinoma & other liver events in HIV/HCV co-infected individuals from 2001 to 2014: a multi-cohort study
- (10/30/15)
EACS:
No decline in hepatitis C incidence among HIV-positive MSM; an update from the CASCADE Collaboration
- (10/30/15)
EACS:
TURQUOISE-I STUDY: USE OF OMBITASVIR/PARITAPREVIR/RITONAVIR + DASABUVIR + RIBAVIRIN IN PATIENTS WITH HCV/HIV-1 CO-INFECTION ON STABLE DARUNAVIR-CONTAINING ANTIRETROVIRAL THERAPY
(10/27/15)
EACS:
ChemSex: Data on Recreational Drug Use and Sexual Behaviour in Men Who Have Sex with Men (MSM) from a Busy Sexual Health Clinic in London, UK
- (11/03/15)
15th European AIDS Conference (EACS)
October 21-24, 2015
Barcelona
View Older Articles
Back to Top
www.natap.org